Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First is scheduled to end on July 31st. Click the link below to learn about your options for continuing care at Temple Health.

Learn More
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH
Back To Doctor Search

Asya Nina Varshavsky-Yanovsky, MD, PhD

Specialties

Hematology Oncology

Loading ...
About Me
Offices
Publications
Ratings & Reviews
About Me
  • Philadelphia Magazine Top Doctors, 2024
  • The Hershel Rich Innovation Award for outstanding research projects, 2011
  • Top 5% Medicine graduates in Israel, 2011
  • Zieff Fine Neeman scholarship award for distinguished students, 2007
Offices

Office Locations

Fox Chase Cancer Center

333 Cottman Avenue

Philadelphia, PA 19111

Phone: 888-369-2427

Fox Chase-Temple University Hospital Bone Marrow Transplant Program

7600 Central Avenue

Patient Care Center, Fifth Floor

Philadelphia, PA 19111

Publications
Publications

Pooja Ghatalia, Chad H. Smith, Arthur Winer, Jiangtao Gou , Lesli A. Kiedrowski, Michael Slifker, Patricia D. Saltzberg, Nicole Bubes, Fern M. Anari, Vineela Kasireddy, Asya Varshavsky , Yang Liu, Eric A. Ross,  Wafik S. El-Deiry  Clinical Utilization Pattern of Liquid Biopsies (LB) to Detect Actionable Driver Mutations, Guide Treatment Decisions and Monitor Disease Burden During Treatment of 33 Metastatic Colorectal Cancer (mCRC) Patients (pts) at a Fox Chase Cancer Center GI Oncology Subspecialty Clinic. Frontiers in Oncology 2019.

Shastri, A., Schinke, C., Varshavsky Yanovsky, A., Bhagat, T. D., Giricz, O.,Barreyro, L., Boultwood, J., Pellagati, A., Yu, Y., Brown, J. R., Frank, D. A.,Das, B., Kambhampati, S., Will, B., Steidl, U., & Verma, A Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine. Blood 2014, 124(21).

Kigel B, Rabinowicz N, Varshavsky A, Kessler O, Neufeld G (2011) Plexin-A4 promotes tumor progression and tumor angiogenesis by enhancement of VEGF and bFGF signaling. Blood. 2011 Aug 10.

Varshavsky A, Kessler O, Abramovitch S, Kigel B, Zaffryar S, Akiri G, Neufeld G (2008) Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin like pro-protein convertases. Cancer research, 68, 6922-6931.

Kigel B, Varshavsky A, Kessler O, Neufeld, G (2008) Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells. PlosOne, 3, e3287.

Gutmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G (2007) Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J. Biol. Chem., 282, 26294-26305.

Neufeld G, Lange T, Varshavsky A, Kessler O (2006) Semaphorin signaling in vascular and tumor biology. Adv. Exp. Med. Biol. 600, 118-131.

Ratings & Reviews

The following ratings and reviews are based on verified feedback collected from independently administered patient experience surveys. The ratings and comments submitted by patients reflect their own views and opinions. Patient identities are withheld to ensure confidentiality and privacy. Learn more about our Patient Experience Ratings.

Ratings Breakdown

Loading ...

Patient Comments

Loading ...